Thus, the effectiveness of PP infusion in decreasing insulin requirements could be correlated with the degree of PP deficiency present in these patients, suggesting a possible therapeutic role of PP in type 1 diabetes mellitus (T1DM), as well as T3cDM patients. This evidence concerns the gene INS and type 1 diabetes mellitus.